GSK secures future of local playing fields with Fields in Trust as part of London 2012 legacy

Issued: London UK

GSK has today entered a partnership with Fields in Trust (FIT) to secure the future of its Swyncombe Avenue Playing Fields, where hundreds of local people already enjoy sport, by placing them into trust in perpetuity. The playing fields will form part of FIT's Queen Elizabeth II Fields Challenge which seeks to protect 2,012 outdoor recreational spaces across the UK as a legacy of the London 2012 Games and HM The Queen?s Diamond Jubilee.

GSK is making a direct contribution to the London 2012 Olympic Games and Paralympic Games by providing the equipment and facilities to enable analysts from King's College London to operate a World Anti-Doping Agency (WADA) accredited laboratory, which will carry out all of the drug testing for the Games. Inspired by GSK's support of the London 2012 Games, the company has pledged to protect the use of its Swyncombe Avenue Playing Fields thereby ensuring current and future generations of employees and local community members will benefit from the outdoor space. The site is located in Brentford, close to GSK's headquarters, which today celebrates its tenth birthday.

Sir Andrew Witty, Chief Executive, GlaxoSmithKline said:
"We are always looking for ways to enthuse and encourage a healthy lifestyle, and the protection of this outdoor space as playing fields will be of great benefit to our employees, the local communities and their future generations."

Alison Moore-Gwyn, Chief Executive, Fields in Trust, said:
"We?re thrilled that GSK is safeguarding its Swyncombe Avenue Sports Ground, making it the first London 2012 partner to join our flagship Queen Elizabeth II Fields Challenge by safeguarding space. The sports ground will become part of the network of fields protected through this grassroots legacy initiative to celebrate the year of the Queen?s Diamond Jubilee and London 2012."

Paul Deighton, Chief Executive, LOCOG, said:
"I am delighted to see GSK demonstrating its commitment to the legacy of the London 2012 Games. This partnership is a great example of how our partners can positively impact future generations by providing sport-related opportunities in the community."

Richard Lewis, Chair, Sport England, said:
"Hundreds of local people play sport on this playing field, so it?s fantastic to see GSK protecting their enjoyment, and that of generations to come, by safeguarding the pitches through the Queen Elizabeth II Fields Challenge. This is a great example of how local communities are benefitting from the Games."

About Swyncombe Avenue Playing Fields: The playing fields cover an area of 4.5 acres, are located in Brentford, close to GSK House (http://gsk.to/K3jT3O) and include: Pavilion, 3 x tennis courts, 2 x 5 A-Side pitches, 11 A-Side pitch, Cricket pitch and nets, Showers and changing facilities for 60

A number of well established clubs and associations use the facilities on a regular basis. The premises are used by 6 cricket teams, 5 football teams and 3 tennis teams, including:GSK Football Team, Brentford Tennis Association, Northfields 11 aside football Team, GSK Greenford Cricket Team, GSK Brentford Cricket Team, GSK Tennis Team.

GSK’s involvement in London 2012:
GSK is the Official Laboratory Services Provider for London 2012, and has formed a partnership with King?s College London (KCL) to provide facilities and equipment to enable experts from KCL to independently operate a World Anti-Doping Agency (WADA) accredited laboratory during the London 2012 Games.

About Fields in Trust:

• The Queen Elizabeth II Fields Challenge is an initiative run by national charity Fields in Trust. The goal is to protect 2,012 outdoor recreational spaces as a legacy from HM The Queen's Diamond Jubilee and the London 2012 Olympic and Paralympic Games.
• HRH The Duke of Cambridge is Patron of the Challenge and supports our aim to ensure communities have access to outdoor spaces for generations to come
• Established in 1925 as the National Playing Fields Association, Fields in Trust works to improve the protection, provision and quality of outdoor recreational spaces for all communities in the UK. The organisation currently protects 1362 fields totalling 8586 acres and further information can be found at http://www.fieldsintrust.org/
• Further details on The Queen Elizabeth II Fields Challenge can be found at http://www.qe2fields.com/

About LOCOG: London 2012 Games partners: The Worldwide Olympic Partners who support the London 2012 Olympic Games and the National Olympic Committees around the world are Coca-Cola, Acer, Atos, Dow, GE, McDonald's, Omega, Panasonic, Procter and Gamble, Samsung and Visa.

LOCOG has seven domestic Tier One Partners - Adidas, BMW, BP, British Airways, BT, EDF and Lloyds TSB. There are seven domestic Tier Two Supporters – Adecco, ArcelorMittal, Cadbury, Cisco, Deloitte, Thomas Cook and UPS. There are now twenty-eight domestic Tier Three Suppliers and Providers – Aggreko, Airwave, Atkins, Boston Consulting Group, CBS Outdoor, Crystal CG, Eurostar, Freshfields Bruckhaus Deringer LLP, G4S, GSK, Gymnova, Heathrow Airport, Heineken UK, Holiday Inn, John Lewis, McCann Worldgroup, Mondo, NATURE VALLEY, Next, Nielsen, Populous, Rapiscan Systems, Rio Tinto, Technogym, Thames Water, Ticketmaster, Trebor and Westfield.

There is one domestic Tier One Paralympic Games-only Partner, Sainsbury?s and one domestic Tier Three Paralympic Games-only Supplier, Otto Bock. The London 2012 Olympic and Paralympic Games also acknowledges the support of the National Lottery.

GlaxoSmithKline
One of the world?s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com

GlaxoSmithKline cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk factors' in the 'Financial review & risk' section in the company's Annual Report 2011 included as exhibit 15.2 to the company's Annual Report on Form 20-F for 2011.